1. Home
  2. AURA vs DIN Comparison

AURA vs DIN Comparison

Compare AURA & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • DIN
  • Stock Information
  • Founded
  • AURA 2007
  • DIN 1958
  • Country
  • AURA United States
  • DIN United States
  • Employees
  • AURA N/A
  • DIN N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • DIN Restaurants
  • Sector
  • AURA Health Care
  • DIN Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • DIN Nasdaq
  • Market Cap
  • AURA 398.1M
  • DIN 468.5M
  • IPO Year
  • AURA 2021
  • DIN 1991
  • Fundamental
  • Price
  • AURA $7.51
  • DIN $25.80
  • Analyst Decision
  • AURA Strong Buy
  • DIN Hold
  • Analyst Count
  • AURA 4
  • DIN 8
  • Target Price
  • AURA $23.00
  • DIN $36.83
  • AVG Volume (30 Days)
  • AURA 139.9K
  • DIN 523.6K
  • Earning Date
  • AURA 03-26-2025
  • DIN 03-05-2025
  • Dividend Yield
  • AURA N/A
  • DIN 7.86%
  • EPS Growth
  • AURA N/A
  • DIN 25.34
  • EPS
  • AURA N/A
  • DIN 6.02
  • Revenue
  • AURA N/A
  • DIN $813,838,000.00
  • Revenue This Year
  • AURA N/A
  • DIN N/A
  • Revenue Next Year
  • AURA N/A
  • DIN $0.60
  • P/E Ratio
  • AURA N/A
  • DIN $4.31
  • Revenue Growth
  • AURA N/A
  • DIN N/A
  • 52 Week Low
  • AURA $6.63
  • DIN $25.67
  • 52 Week High
  • AURA $12.38
  • DIN $51.35
  • Technical
  • Relative Strength Index (RSI)
  • AURA 38.25
  • DIN 35.37
  • Support Level
  • AURA $7.50
  • DIN $25.83
  • Resistance Level
  • AURA $8.16
  • DIN $27.81
  • Average True Range (ATR)
  • AURA 0.31
  • DIN 1.21
  • MACD
  • AURA -0.02
  • DIN -0.20
  • Stochastic Oscillator
  • AURA 1.30
  • DIN 2.39

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations, and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

Share on Social Networks: